SCHEMBL3645797

SCHEMBL3645797

CONC(=O)c1ccc(C)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
GAA P10253 1/20 0.61
RAB9A P51151 6/20 0.59
NPC1 O15118 4/20 0.59
TDP1 Q9NUW8 2/20 0.59
HDAC1 Q13547 2/20 0.59
HDAC6 Q9UBN7 2/20 0.59
KMT2A Q03164 2/20 0.56
MMP13 P45452 1/20 0.53
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
LMNA P02545 2/20 0.50
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28647585 0.83 MAPT (0.50) ALDH1A1GAARAB9AKMT2ALMNA
SCHEMBL27951738 0.83 MAPT (0.70) ALDH1A1GAARAB9ANPC1TDP1
SCHEMBL14602517 0.83 LMNA (0.55) ALDH1A1GAARAB9ANPC1TDP1
SCHEMBL9402939 0.83 CA1 (0.59) ALDH1A1GAARAB9ANPC1KMT2A
SCHEMBL23921253 0.83 ALDH1A1 (0.61) ALDH1A1GAARAB9ANPC1TDP1
SCHEMBL8638149 0.81 ALDH1A1 (0.61) ALDH1A1RAB9ANPC1TDP1KMT2A
SCHEMBL8547880 0.81 RAB9A (0.56) GAARAB9ANPC1HDAC1HDAC6
SCHEMBL10763261 0.81 MAPT (0.47) ALDH1A1GAARAB9ANPC1KMT2A
SCHEMBL27916996 0.81 OGG1 (0.61) ALDH1A1GAARAB9ANPC1HDAC1
SCHEMBL5592540 0.81 MAPT (0.47) ALDH1A1GAARAB9ANPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113735756-B Method for synthesizing chiral 3, 3-disubstituted isoindolinone compound by rhodium catalysis 陕西师范大学 2024-04-26 CN disclosed
WO-2023122298-A1 PROTEIN STABILIZING COMPOUNDS CONTAINING USP28 AND/OR USP25 TARGETING LIGANDS Stablix, Inc. (US) 2023-06-29 WO disclosed
CN-113149868-B Method for synthesizing axichiral diene compound by trivalent rhodium catalysis 陕西师范大学 2023-05-23 CN disclosed
CN-115433222-A Preparation method and application of 2- (gem-difluoropropylene) benzamide compound 五邑大学 2022-12-06 CN disclosed
CN-115368272-A Preparation method of 4-cyano-2-methoxybenzaldehyde 汉瑞药业(荆门)有限公司 2022-11-22 CN disclosed
CN-113735756-A Method for synthesizing chiral 3, 3-disubstituted isoindolinone compound by rhodium catalysis 陕西师范大学 2021-12-03 CN disclosed
CN-113149868-A Method for synthesizing axial chiral allene compound by using trivalent rhodium as catalyst 陕西师范大学 2021-07-23 CN disclosed
CN-110305062-B Substituted isoquinolone compound and synthesis method and application thereof 广州医科大学 2021-01-05 CN disclosed
CN-107082761-B Phenanthridinone or benzophenanthridinone derivative and synthesis method thereof 上海大学 2020-04-03 CN disclosed
US-7897609-B2 Aryl substituted imidazonaphthyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-03-01 US disclosed
US-20090029990-A1 Dihydropteridinones in the treatment of respiratory diseases MAIER UDO 2009-01-29 US disclosed
WO-2009001132-A1 PYRAZINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF LUNG DISEASES ASTRAZENECA AB (SE) 2008-12-31 WO disclosed
US-20070219228-A1 Aryl substituted imidazonaphthyridines 3M INNOVATIVE PROPERTIES COMPANY 2007-09-20 US disclosed
US-20070219228-A1 Aryl substituted imidazonaphthyridines 3M INNOVATIVE PROPERTIES COMPANY 2007-09-20 US disclosed
WO-2007075468-A1 SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZONAPHTHYRIDINES, AND IMIDAZOPYRIDINES, COMPOSITIONS, AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-07-05 WO disclosed
US-20070043055-A1 Dihydropteridinones in the treatment of respiratory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-22 US disclosed
US-6576765-B2 Process for preparing amic acid esters IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2003-06-10 US disclosed
US-20030032667-A1 PROCESS FOR PREPARING AMIC ACID ESTERS IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2003-02-13 US disclosed
EP-1182199-A1 PROCESS FOR PREPARING AMIC ACID ESTERS IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2002-02-27 EP disclosed
US-5319123-A Reacting an N-alkoxyamide with an acyl halide in the presence of a hindered base SANDOZ LTD. (CH) 1994-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043055-A1 Dihydropteridinones in the treatment of respiratory diseases QDPR, DHPS, NDUFS6 ALDH1A1 1078/4885GAA 2532/4885RAB9A 2056/4885
US-20070219228-A1 Aryl substituted imidazonaphthyridines IL2, IRF3, EIF2AK2 ALDH1A1 1178/4885GAA 1064/4885RAB9A 2097/4885
US-20030032667-A1 PROCESS FOR PREPARING AMIC ACID ESTERS MCCC2, EMC1, GANC ALDH1A1 651/4885GAA 853/4885RAB9A 774/4885
US-20090029990-A1 Dihydropteridinones in the treatment of respiratory diseases QDPR, DHPS, NDUFS6 ALDH1A1 1078/4885GAA 2532/4885RAB9A 2056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.